Late stage scientific pharmaceutical firm XORTX Therapeutics (NASDAQ:XRTX) acquired notification from the Nasdaq that it’s not in compliance with the minimal bid worth requirement because the closing bid worth for the corporate’s frequent shares listed on Nasdaq was under US$1.00 for 30 consecutive enterprise days.
The corporate has a interval of 180 calendar days from the date of notification to regain compliance with the minimal bid worth requirement.
